Targeting a cell surface RNA-binding protein driving acute myeloid leukemia

kisded kisdedUncategorized1 week ago25 Views

  • Research Briefing
  • Published:

Nature Biotechnology

(2025)Cite this article

Subjects

How modifications to RNA molecules and the proteins they interact with on the cell surface contribute to cancer is largely unknown. Preclinical evidence indicates that cell surface nucleophosmin (NPM1, an RNA-binding protein) is a novel druggable biomarker in acute myeloid leukemia, with potential implications for improving detection and immunotherapy strategies for several cancer types.

This is a preview of subscription content, access via your institution

Access options

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

24,99 € / 30 days

cancel any time

Subscribe to this journal

Receive 12 print issues and online access

195,33 € per year

only 16,28 € per issue

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Nanoscale distribution of cell surface NPM1 and its therapeutic effect on AML in vivo.

References

  1. Box, J. K. et al. Nucleophosmin: from structure and function to disease development. BMC Mol. Biol. 17, 19 (2016). A review article that summarizes the biology of NPM1 and its relevance in disease.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  2. Perr, J. et al. RNA-binding proteins and glycoRNAs form domains on the cell surface for cell-penetrating peptide entry. Cell 188, 1878–1895.e25 (2025). This paper reports our characterization of cell surface RBPs and their role in regulating cell entry of cell-penetrating peptides.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: George, B. M. et al. Treatment of acute myeloid leukemia models by targeting a cell surface RNA-binding protein. Nat. Biotechnol. https://doi.org/10.1038/s41587-025-02648-2 (2025).

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Targeting a cell surface RNA-binding protein driving acute myeloid leukemia.
Nat Biotechnol (2025). https://doi.org/10.1038/s41587-025-02695-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41587-025-02695-9

Read More

0 Votes: 0 Upvotes, 0 Downvotes (0 Points)

Leave a reply

Recent Comments

No comments to show.

Stay Informed With the Latest & Most Important News

I consent to receive newsletter via email. For further information, please review our Privacy Policy

Advertisement

Loading Next Post...
Follow
Sign In/Sign Up Sidebar Search Trending 0 Cart
Popular Now
Loading

Signing-in 3 seconds...

Signing-up 3 seconds...

Cart
Cart updating

ShopYour cart is currently is empty. You could visit our shop and start shopping.